Got our #monovalent #covid boosters this morning, picked up some breakfast and beers, and am chillin’ on the couch. 4 hours in and I’m feeling fine, minus some sleepiness, but that may just be from being old. Wife who usually has a more severe response to the vaccines seems fine so far. Fingers crossed 🤞
#monovalent
https://www.nytimes.com/2023/09/11/well/live/covid-vaccine-booster-fall.html?unlocked_article_code=CX_aiQ9zuebxMs-2tLh27qbu95Exj52UULSuwz1asqr_cKSsBy2oYOgVxAQ3HhJd0J8PD9jSe4z94PBxF9zK4b0WPy6bM_e9dnzIjNqOL3DmvXzuj7yGHbQ5gflXMfx_AvuJ4RZ3VfoELpDyvOFsl9ogtLnvevPyMvGKqjnj0kCTLiGNBOnYL0Tcwg0vqlUTJJxivPRFXO1XMQs0MP6lBe2JXOqdKKpGWG502FdkjZlTe-zMMgZ7CDe_Fnj8P1VN5I0D6y6Kh5g25gIxe4malgV4sjkmjXbZqqhMVmph7Ze9nRTA2YTrfOWUSKr5fPpaWgeqlDQ1rXw7xZ5vtZibT92p_tdHQQ&smid=nytcore-ios-share&referringSource=articleShare “Regulators will also consider a third #monovalent shot developed by #Novavax against #xbb15 in the coming months”
CONSIDER?!?!?!
IN THE COMING MONTHS?!?!?!
ARE YOU DCUKIJF KIDDING ME?!?!?!!!!!!
#pfizer #moderna #bigPharma #corruption #FDA #CDC #ACIP
🤬🤬🤬🤬🤬🤬🤬🤬🤬🤬
I hate the #NYT but keep it for the Food App, & instead of excercise read it to raise my #BP #assholes
Come and get it! If you can afford it 🤬
The #COVID #XBB #variant family #booster approved in the #US for everyone older than 5 and will start being available by the end of this week. Price will be an obscene $100 per dose.
#Health "#insurance" *should* cover the cost, in-network, but we know how insurance finds ways to not ensure our health.
Good news is "It is likely that the XBB.1.5 #monovalent #vaccines will raise #antibodies against all the circulating variants"
https://www.nbcnews.com/health/health-news/fda-clears-new-covid-boosters-5-things-know-rcna102577
With coronavirus on the upswing, new vaccine coming (ever so slightly) sooner than expected
The U.S. Food and Drug Administration said this year’s updated version of the COVID-19 vaccine is likely to come out by the middle of next month, a bit earlier than the late September timeline previously announced by the Department of Health and Human Services.
The earlier-than-expected arrival became apparent after the U.S. Centers for Disease Control and Prevention scheduled a Sept. 12 meeting of its Advisory Committee on Immunization Practices, a likely indication that the vaccine would become available shortly afterward.
The latest version of the vaccine is designed against the Omicron subvariant XBB.1.5, unofficially known as #Kraken.
Unlike last year’s formulation, a bivalent vaccine that was designed against both the ancestral coronavirus strain and the BA.5/BA.4 Omicron subvariants that were circulating at the time, the upcoming vaccine will be #monovalent, specifically designed against #XBB.1.5.
Effectiveness of #bivalent #mRNA #vaccines against medically attended #symptomatic #SARSCoV2 infection and #COVID19-related #HospitalAdmission among SARS-CoV-2-naive and previously infected individuals: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00373-0/fulltext “A fourth dose with the bivalent vaccine was substantially more effective against medically attended symptomatic SARS-CoV-2 infection and COVID-19-related hospital admission than four #monovalent doses among both SARS-CoV-2-naive and previously infected individuals.”
Our fall COVID boosters will likely be a monovalent XBB formula
If all goes smoothly, the FDA is expecting new shots around September.
https://arstechnica.com/health/2023/06/our-fall-covid-boosters-will-likely-be-a-monovalent-xbb-formula/ #covid19 #monovalent #vaccine #XBB
Monovalent shots gone
Spring boosters offered instead
Vaccinates take three
[Correspondence] Davis-Gardner, 2022: Serum from recipients of 1x #booster, even when immunity would be at its most potent, showed no response to XBB. #Bivalent booster recipients' serum performed better than 2x #monovalent recipients'. #COVID19
https://www.reddit.com/r/COVIDZero/comments/zt4bwn/correspondence_davisgardner_2022_serum_from/
Client Info
Server: https://mastodon.social
Version: 2025.04
Repository: https://github.com/cyevgeniy/lmst